SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.54+1.4%Dec 15 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (4068)10/13/1997 8:56:00 AM
From: Tharos   of 17367
 
Bob,
With Xoma I tend to say it will move only with news because of its jaded past. I believe this reputation still follows Xoma, possibly confirmed by my mention of it to some circles yielding little more than a laugh. Xoma needs a significant announcement, like completion of PIII mennin trials, to regain credibility loss from its previous sepsis/E5 debacle. An affair which lasted years if you count the time between failing statistical testing and this summer's final cancellation of efforts to bring the product to market.

Without a doubt Xoma's price-plot story is a matter of interpretation and different "tea leaf readers" will tell the story in their own way. The stock consolidated from its decline but was unable break out above $8 for an entire year before finishing its plunge from $33+ to $1+. We are now in the third attempt in the last year and one-half to break out above $8. This eight-dollar resistance area appears to me to be the last serious one, based on the stock's price history. Nine-dollars appears to be a support area for prices above it. I added to the bottom of my web page a price plot going back to April 87. I hope this helps explains why I suggest the undecided wait for a close above $9 as a "safer" ploy.

geocities.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext